Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
Clinical trial NCT07451665 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07451665
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2029-03-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.